Arterial Disorder
Arterial disorders encompass a range of conditions affecting the arteries, the vital blood vessels responsible for transporting oxygen-rich blood from the heart to various tissues and organs throughout the body. These disorders often involve structural or functional abnormalities of the arterial walls, such as hardening, narrowing, or weakening, which can impede blood flow and compromise organ function.
The biological basis of arterial disorders is complex, involving a combination of genetic predispositions and environmental factors. Genetic research, particularly genome-wide association studies (GWAS), has begun to identify specific genetic variants associated with traits like arterial stiffness. For instance, theCOL4A1gene has been identified as being associated with arterial stiffness[1]. This genetic link highlights the role of inherited factors in the development and progression of arterial pathologies. Research, including work originating from the Framingham Heart Study 100K Project, has explored genome-wide associations for blood pressure and arterial stiffness[1].
Clinically, arterial disorders are highly relevant due to their significant impact on cardiovascular health. Conditions such as atherosclerosis, hypertension (high blood pressure), and aneurysms can lead to severe health consequences, including myocardial infarction (heart attack), stroke, peripheral artery disease, and kidney failure. Early detection and management of these disorders are crucial for preventing adverse outcomes.
From a societal perspective, arterial disorders represent a major public health challenge globally. They contribute substantially to morbidity and mortality rates, placing a considerable burden on healthcare systems and diminishing the quality of life for affected individuals. Understanding the genetic underpinnings of these conditions can pave the way for improved risk assessment, targeted prevention strategies, and the development of novel therapeutic interventions, ultimately aiming to reduce their widespread impact.
Limitations in Genetic Association Studies for Arterial Disorder
Section titled “Limitations in Genetic Association Studies for Arterial Disorder”1. Methodological and Statistical ConstraintsThe interpretation of genetic association findings for complex conditions like arterial disorder is subject to several methodological and statistical limitations. The statistical power of genome-wide association studies (GWAS) is critically dependent on sample size; while large cohorts can yield robust associations with very low p-values, smaller studies may lack the power to detect genetic variants with subtle effects, including rare alleles or structural variants[2]. Consequently, a failure to identify a significant genetic association does not definitively rule out a gene’s involvement, as it could be attributed to insufficient power or incomplete genomic coverage by the genotyping platforms [2]. This can lead to an incomplete understanding of the genetic architecture underlying arterial disorder.
Furthermore, initial strong association signals often require independent replication to confirm their validity and mitigate effect-size inflation, where the reported effect in discovery cohorts may be an overestimate of the true effect[2]. The necessity for rigorous replication underscores that even highly significant initial findings serve as strong evidence for association rather than conclusive proof, necessitating further validation in independent populations. This iterative process is fundamental for distinguishing true genetic signals from spurious associations and establishing reliable susceptibility loci for arterial disorder.
2. Phenotypic Heterogeneity and Population SpecificityDefining and consistently measuring complex phenotypes, such as specific manifestations or quantitative traits related to arterial disorder, presents a significant challenge in genetic studies[3]. Variations in diagnostic criteria, symptom presentation, or the precision of quantitative measurements can introduce substantial heterogeneity within study cohorts. This phenotypic variability may dilute true genetic signals, leading to associations with specific subtypes of arterial disorder rather than the broader condition, or necessitate the use of both “broad” and “narrow” case definitions, which can impact the generalizability of findings[4].
Moreover, genetic associations identified primarily in populations of specific ancestries may not be universally applicable to other populations due to differences in linkage disequilibrium patterns, allele frequencies, or varying environmental exposures. While studies often implement methods like multidimensional scaling to control for population stratification, the underlying genetic architecture can differ across diverse ethnic groups [5]. This limits the direct transferability of findings for arterial disorder across global populations and highlights the need for caution when extrapolating results to individuals of different ancestral backgrounds.
3. Complex Etiology and Unaccounted FactorsArterial disorder, like many complex human diseases, is influenced by a multitude of genetic and environmental factors, alongside intricate gene-environment interactions. Current GWAS methodologies primarily focus on identifying common genetic variants with independent effects, often failing to fully capture the complex interplay between genes, environmental exposures, or other modifying genetic factors[6]. Unmeasured or uncontrolled environmental confounders can obscure genuine genetic signals or lead to spurious associations, thereby complicating efforts to fully elucidate the comprehensive etiology of arterial disorder.
Despite considerable progress, the identified genetic variants frequently account for only a fraction of the estimated heritability for complex traits, a phenomenon commonly referred to as “missing heritability.” This suggests that a significant portion of genetic influence, including contributions from rare variants, structural variants, epigenetic modifications, or complex gene-gene interactions, remains undiscovered or unquantified [2]. Furthermore, for certain hypothesized genetic mechanisms, such as the involvement of ion channel variants in common forms of diseases, strong evidence may still be lacking, indicating persistent knowledge gaps in understanding the full spectrum of genetic susceptibility to arterial disorder[7]. Addressing these limitations necessitates continued research employing more sophisticated methodologies to uncover the complete genetic landscape.
Variants
Section titled “Variants”The PRRG4gene (Proline Rich Gla Protein 4) contributes to various cellular processes, primarily as a member of the Gla protein family, which are recognized for their ability to bind calcium. These proteins are integral to several physiological functions, notably including vascular health and the regulation of calcification, a process closely associated with arterial stiffness[1]. The variant rs149859005 , situated within an intron of the PRRG4 gene, may influence gene expression or protein function by potentially affecting messenger RNA (mRNA) splicing or stability. The comprehensive understanding of such genetic contributions is vital for unraveling the intricate causes of common conditions, as evidenced by extensive genome-wide association studies exploring a wide range of human traits [2].
Variations such as rs149859005 have the potential to subtly alter the normal activity of PRRG4, thereby impacting its role in vascular biology. While the specific functional consequences of this intronic variant require further investigation, modifications in Gla protein function can lead to downstream effects on the integrity and elasticity of arterial walls, and potentially influence susceptibility to atherosclerotic processes. The ongoing efforts in genetic epidemiology consistently uncover new associations between specific genetic markers and complex diseases, including those that affect the cardiovascular system[3]. These discoveries underscore the complex interplay between an individual’s genetic makeup and their risk of developing conditions like arterial disorder, highlighting the critical role of detailed genetic analysis in personalized medicine[8].
Key Variants
Section titled “Key Variants”| RS ID | Gene | Related Traits |
|---|---|---|
| rs149859005 | PRRG4 | arterial disorder |
Classification, Definition, and Terminology
Section titled “Classification, Definition, and Terminology”Defining Arterial Disorder: The Role of Arterial Stiffness
Section titled “Defining Arterial Disorder: The Role of Arterial Stiffness”An arterial disorder broadly refers to conditions affecting the arteries, with “arterial stiffness” emerging as a key characteristic and a central concept in its definition. Arterial stiffness is precisely defined as the reduced elasticity of the arterial walls, which impedes their natural ability to expand and contract in response to blood flow . While research highlights these fundamental arterial traits, specific clinical presentation patterns, common subjective symptoms, or severity ranges typically associated with arterial disorder are not detailed.
Genetic Assessment and Diagnostic Implications
Section titled “Genetic Assessment and Diagnostic Implications”Research employs genome-wide association scans as a primary method for assessing the genetic underpinnings of arterial properties. These diagnostic tools have identified genetic variants, such as those within COL4A1, that are associated with arterial stiffness, providing insights into the genetic factors influencing arterial health.[1]. Such genetic correlations may hold diagnostic significance by contributing to an understanding of predisposition to altered arterial characteristics. However, the provided studies do not detail specific objective clinical measurement scales, prognostic indicators, or a comprehensive differential diagnosis for arterial disorder in a clinical setting.
Causes
Section titled “Causes”The development of arterial disorder is primarily influenced by a complex interplay of genetic factors, with robust evidence supporting its heritable nature. Research has extensively focused on identifying specific genetic variants and their impact on arterial health, particularly arterial stiffness.
Inherited Genetic Predisposition
Section titled “Inherited Genetic Predisposition”Arterial disorder, especially arterial stiffness, exhibits a significant heritable component, indicating that genetic factors transmitted across generations play a crucial role in its manifestation. Studies, including those conducted on large cohorts like Sardinians and participants in the Framingham Heart Study, have confirmed the heritability of various cardiovascular traits and arterial stiffness itself[9]. This strong heritability suggests that an individual’s unique genetic makeup can predispose them to a higher risk of developing arterial stiffening. The condition often arises from complex polygenic influences, where numerous genetic variants, each contributing a small effect, collectively increase susceptibility [2].
Specific Genetic Associations
Section titled “Specific Genetic Associations”Genome-wide association studies (GWAS) have been instrumental in pinpointing specific genetic loci linked to arterial stiffness. For example, the geneCOL4A1has been directly associated with arterial stiffness through genome-wide scans, highlighting its importance in the structural integrity and function of arterial walls[1]. Beyond COL4A1, broader genome-wide associations have been identified for both arterial stiffness and blood pressure, suggesting that a network of genes collectively influences overall arterial health[10]. Furthermore, research indicates that the genetic risk for related conditions, such as myocardial infarction, can be determined by polymorphisms within specific candidate genes, further emphasizing the impact of precise genetic variations on vascular health [11].
Molecular Mechanisms and Gene Expression
Section titled “Molecular Mechanisms and Gene Expression”The quantitative relationship between gene expression and arterial stiffness offers critical insights into the molecular mechanisms underlying arterial disorder. Variations in the activity levels of certain genes can directly influence the physiological properties of human arteries, contributing to their stiffness[12]. These genetic expressions can affect the synthesis and regulation of key components within the arterial wall, such as collagen and elastin, which are vital for maintaining arterial elasticity and function. Consequently, the intricate control of gene expression plays a fundamental role in determining both the susceptibility to and the progression of arterial stiffness.
Biological Background of Arterial Disorders
Section titled “Biological Background of Arterial Disorders”Arterial disorders encompass a range of conditions characterized by structural and functional abnormalities of the arteries, impacting blood flow and overall cardiovascular health. These disorders often involve complex interactions between genetic predispositions, molecular pathways, and environmental factors, leading to progressive changes in arterial tissue. Understanding the underlying biological mechanisms is crucial for comprehending their development and systemic consequences.
Genetic Predisposition and Regulatory Networks
Section titled “Genetic Predisposition and Regulatory Networks”Genetic factors play a significant role in determining an individual’s susceptibility to arterial disorders. Genome-wide association studies are instrumental in identifying specific genetic variants and genes associated with traits like arterial stiffness[1]. These studies aim to uncover the regulatory networks and gene functions that influence arterial health, revealing how variations in DNA sequences can impact the development or progression of these conditions. The identification of such genetic loci provides insights into the inherent biological pathways that govern arterial structure and function.
Pathophysiological Mechanisms of Arterial Dysfunction
Section titled “Pathophysiological Mechanisms of Arterial Dysfunction”Arterial disorders are fundamentally characterized by pathophysiological processes that disrupt the normal homeostatic balance of the vascular system. A key manifestation is arterial stiffness, where the arteries lose their natural elasticity, thereby impeding their ability to effectively dampen pulsatile blood flow[1]. This stiffening represents a significant deviation from healthy arterial function, leading to altered hemodynamics and increased resistance to blood flow. These disruptions contribute to a cascade of events that can affect the entire cardiovascular system.
Key Molecular Components and Cellular Functions
Section titled “Key Molecular Components and Cellular Functions”The structural integrity and functional properties of arterial walls are maintained by a complex array of key biomolecules and cellular processes. Critical proteins, such as collagen type IV alpha 1 chain (COL4A1), are essential structural components that contribute to the architecture and mechanical properties of arterial tissue [1]. Variations within genes like COL4A1 can influence the composition and organization of the extracellular matrix, thereby affecting the elasticity and overall health of the arterial wall. Understanding these molecular players and their cellular functions is vital for elucidating the mechanisms behind arterial stiffening and other disorders.
Systemic Impact and Organ-Level Consequences
Section titled “Systemic Impact and Organ-Level Consequences”The localized changes within arterial walls have broad systemic consequences, affecting multiple organs and body systems. Arterial stiffness, for example, is directly linked to alterations in blood pressure, contributing to hypertension and increased cardiovascular risk[1]. The reduced elasticity of the arteries forces the heart to work harder, and the altered blood flow can negatively impact organ-specific functions, including those of the kidneys and brain. These tissue interactions and systemic disruptions highlight the interconnected nature of arterial health with overall physiological well-being.
Pathways and Mechanisms
Section titled “Pathways and Mechanisms”Arterial disorders, characterized by conditions like arterial stiffness, involve complex interplay among various molecular pathways and cellular mechanisms within the arterial wall. A genome-wide association scan has identified an association between COL4A1 and arterial stiffness[1]. This highlights the importance of structural components and their regulation in maintaining vascular health. The mechanisms contributing to arterial disorders can be broadly categorized into the following areas.
Structural Integrity and Extracellular Matrix Dynamics
Section titled “Structural Integrity and Extracellular Matrix Dynamics”Arterial stiffness, a hallmark of arterial disorder, is fundamentally linked to alterations in the composition and organization of the extracellular matrix (ECM) within the arterial wall. COL4A1, as a critical component of collagen type IV, plays an essential role in forming the basement membranes that support arterial cells and maintain the artery’s mechanical properties. Dysregulation in the expression, synthesis, or assembly of COL4A1 can directly compromise the structural integrity and elasticity of the vascular tissue. Such changes can lead to a less compliant artery, increasing its stiffness and contributing to the progression of arterial disease.
Cellular Signaling and Mechanotransduction
Section titled “Cellular Signaling and Mechanotransduction”Beyond its structural role, the extracellular matrix, including proteins like COL4A1, actively participates in transmitting signals that influence cellular behavior within the arterial wall. Interactions between arterial cells and their surrounding matrix can activate specific receptor-mediated signaling pathways, initiating intracellular cascades that impact cell proliferation, migration, and differentiation. Alterations in the COL4A1 network could therefore modulate mechanotransduction, the process by which cells sense and respond to mechanical forces. This signaling crosstalk is vital for maintaining arterial wall homeostasis and contributes to the overall network interactions governing vascular remodeling.
Metabolic Regulation of Arterial Components
Section titled “Metabolic Regulation of Arterial Components”The construction and maintenance of the arterial wall are energy-intensive processes, with metabolic pathways critically regulating the biosynthesis and catabolism of structural proteins such as COL4A1. Energy metabolism provides the necessary ATP and precursors for the synthesis of collagen, while catabolic pathways ensure the proper turnover and remodeling of the ECM. Precise metabolic regulation, including flux control of nutrient availability and enzymatic activities, directly influences the quantity and quality of COL4A1 produced and integrated into the arterial matrix. Disruptions in these tightly controlled metabolic processes can lead to an imbalance in ECM dynamics, thereby contributing to pathological changes like increased arterial stiffness.
Transcriptional and Post-Translational Control
Section titled “Transcriptional and Post-Translational Control”The production of key arterial components, including COL4A1, is subject to stringent regulatory mechanisms operating at multiple levels. Gene regulation ensures appropriate expression of COL4A1 through the intricate control of transcription factors, which are themselves often modulated by upstream signaling pathways and feedback loops. Furthermore, after synthesis, COL4A1 undergoes extensive post-translational modifications, such as hydroxylation and glycosylation, which are crucial for its correct folding, assembly, and functional integration into the basement membrane. Any dysregulation in these sophisticated regulatory steps, whether at the level of gene transcription or protein modification, can result in functionally impaired COL4A1, contributing to the development and progression of arterial disorders.
Pathway Dysregulation and Therapeutic Targets
Section titled “Pathway Dysregulation and Therapeutic Targets”The association of COL4A1 with arterial stiffness indicates a specific pathway dysregulation that contributes to arterial disorder[1]. When the delicate balance of COL4A1 synthesis, modification, and integration into the extracellular matrix is disturbed, the emergent mechanical properties of the artery are compromised, leading to increased stiffness. Understanding these molecular and cellular mechanisms of dysregulation can illuminate potential compensatory mechanisms that the body might employ to mitigate the damage. Moreover, identifying the specific points of failure within these pathways can reveal novel therapeutic targets, offering avenues for interventions aimed at modulating COL4A1 expression, enhancing its proper function, or counteracting the detrimental effects of its dysfunction in arterial disorders.
Population Studies
Section titled “Population Studies”Population studies of arterial disorder leverage large cohorts and advanced genetic methodologies to uncover underlying risk factors, prevalence patterns, and population-level implications. These studies are crucial for understanding the complex interplay of genetic and environmental factors contributing to the disease burden.
Genetic Epidemiology and Large-Scale Cohort Investigations
Section titled “Genetic Epidemiology and Large-Scale Cohort Investigations”Large-scale cohort studies have been instrumental in identifying genetic predispositions to arterial disorders. A genome-wide association scan, for instance, identified that the COL4A1gene is associated with arterial stiffness[1]. This finding emerged from investigations that included data from projects like the Framingham Heart Study 100K Project, a significant example of a major population cohort used for genome-wide associations related to cardiovascular traits[1]. Such studies utilize comprehensive genetic data alongside clinical measurements collected over time, allowing researchers to pinpoint specific genetic variants that contribute to the development or progression of arterial stiffness, a key indicator of arterial disorder.
The integration of genetic insights from biobank studies and longitudinal cohorts provides a robust framework for understanding the temporal patterns of arterial disorders. By analyzing genetic variants in large populations, these studies aim to identify individuals at higher risk, track disease progression over decades, and explore how genetic factors interact with lifestyle and environmental exposures. The scale of such endeavors, often involving thousands of cases and controls, is critical for detecting common susceptibility variants for complex diseases[2], including those affecting arterial health.
Epidemiological Associations and Methodological Approaches
Section titled “Epidemiological Associations and Methodological Approaches”Epidemiological studies employing diverse methodologies are essential for mapping the prevalence and incidence patterns of arterial disorders across various demographics. While specific prevalence rates for arterial disorder are not detailed in all genetic studies, the identification of genetic associations, such as that ofCOL4A1with arterial stiffness, contributes directly to understanding the underlying risk architecture that drives these population-level patterns[1]. Such findings can inform public health strategies and targeted interventions.
Methodologically, population genetic studies often rely on genome-wide association scans (GWAS) to systematically search for common genetic variants associated with traits or diseases. These studies require large sample sizes to achieve sufficient statistical power, as exemplified by consortia undertaking analyses of thousands of cases and controls [2]. Beyond basic association tests, advanced methods like propensity score-based nonparametric tests are sometimes employed to rigorously evaluate genetic variants and minimize confounding [8], ensuring the robustness and generalizability of identified associations in diverse study designs.
Cross-Population and Generalizability Considerations
Section titled “Cross-Population and Generalizability Considerations”Understanding cross-population differences is critical for a comprehensive view of arterial disorder epidemiology. Genetic susceptibility and environmental risk factors can vary significantly across different ancestries, geographic regions, and ethnic groups, leading to population-specific effects on disease prevalence and severity. While specific cross-population comparisons for arterial stiffness were not detailed in the provided genetic association study, the general principles of population genetics emphasize the importance of studying diverse cohorts to capture the full spectrum of genetic and environmental influences.
The representativeness of study samples directly impacts the generalizability of findings to broader populations. Discoveries made in predominantly homogenous populations may not be universally applicable, highlighting the need for research that includes a wide array of demographic groups. Future population studies on arterial disorders will increasingly focus on multi-ethnic cohorts to identify ancestry-specific genetic variants and environmental interactions, ultimately leading to more equitable and effective prevention and treatment strategies tailored to diverse global populations.
Frequently Asked Questions About Arterial Disorder
Section titled “Frequently Asked Questions About Arterial Disorder”These questions address the most important and specific aspects of arterial disorder based on current genetic research.
1. My parents have stiff arteries. Will I definitely get them too?
Section titled “1. My parents have stiff arteries. Will I definitely get them too?”Not necessarily. While genetic predispositions play a role, like variations in genes such as COL4A1that are linked to arterial stiffness, your lifestyle choices also significantly influence your risk. Eating healthy, exercising, and managing stress can help reduce your chances, even with a family history.
2. Can I really prevent heart problems if they run in my family?
Section titled “2. Can I really prevent heart problems if they run in my family?”Yes, absolutely. Even if you have a genetic predisposition, environmental factors and lifestyle choices are very important. Regular exercise, a balanced diet, and avoiding smoking can significantly reduce your risk of developing conditions like atherosclerosis or high blood pressure, despite your family history.
3. Is a genetic test useful for predicting my arterial health risk?
Section titled “3. Is a genetic test useful for predicting my arterial health risk?”Genetic tests can identify specific variants associated with conditions like arterial stiffness, offering insights into your predisposition. However, these tests usually only explain a fraction of your overall risk, as many factors contribute. It’s best to discuss the results with a doctor who can combine them with your lifestyle and other health markers for a comprehensive assessment.
4. Why do some people get high blood pressure but others don’t?
Section titled “4. Why do some people get high blood pressure but others don’t?”It’s a complex mix of genetics and environment. Some people inherit genetic variants that make them more susceptible to conditions like high blood pressure, while others have different genetic profiles. Lifestyle choices like diet, exercise, and stress also interact with these genetic factors, leading to varied outcomes even among family members.
5. Does my ethnic background affect my risk for arterial issues?
Section titled “5. Does my ethnic background affect my risk for arterial issues?”Yes, research suggests that genetic associations can differ across populations due to variations in genetic makeup and environmental exposures. Findings from one ethnic group may not directly apply to another. This highlights why diverse studies are crucial for understanding risk across all ancestries.
6. Could subtle things, like my pulse, show artery problems?
Section titled “6. Could subtle things, like my pulse, show artery problems?”While a regular pulse is good, arterial stiffness, a subtle sign of potential issues, can be measured through specific tests. Researchers use methods like pulse wave velocity to assess how stiff your arteries are, which can indicate an early risk for future cardiovascular problems.
7. What does “hardening of arteries” actually mean for my body?
Section titled “7. What does “hardening of arteries” actually mean for my body?”“Hardening of arteries” means your artery walls lose their elasticity and become stiff, often due to plaque buildup. This makes it harder for blood to flow smoothly, increasing your blood pressure and strain on your heart. Over time, it can lead to serious conditions like heart attack or stroke.
8. Does stress actually make my arteries worse, or is that a myth?
Section titled “8. Does stress actually make my arteries worse, or is that a myth?”Stress can indeed contribute to arterial problems. While genetics lay a foundation, environmental factors like chronic stress can influence how those genes are expressed and impact your cardiovascular system. Managing stress is an important part of maintaining good arterial health.
9. Why do some people never gain weight, but I struggle with artery issues?
Section titled “9. Why do some people never gain weight, but I struggle with artery issues?”Arterial disorders are influenced by many complex genetic and environmental factors, not just weight. You might have genetic predispositions that affect your arterial health independently, or in combination with other lifestyle factors, even if your weight is not a primary concern.
10. Can healthy eating overcome my bad family history for arteries?
Section titled “10. Can healthy eating overcome my bad family history for arteries?”Healthy eating and lifestyle choices are powerful tools, even with a strong family history. While you can’t change your genes, you can significantly modify how they express themselves by making healthy choices. This can help delay onset or reduce the severity of arterial disorders, improving your overall cardiovascular health.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
Section titled “References”[1] Tarasov, K. V., et al. “COL4A1 is associated with arterial stiffness by genome-wide association scan.”Circ Cardiovasc Genet, 2009.
[2] Wellcome Trust Case Control Consortium. “Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.” Nature, vol. 447, no. 7145, 2007, pp. 661-678.
[3] Lasky-Su, J. et al. “Genome-wide association scan of the time to onset of attention deficit hyperactivity disorder.” American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol. 147B, no. 8, 2008, pp. 1358–64.
[4] Shyn, S. I. et al. “Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.” Molecular Psychiatry, vol. 15, no. 12, 2010, pp. 1169–79.
[5] Cichon, S. et al. “Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder.” American Journal of Human Genetics, vol. 88, no. 3, 2011, pp. 372–81.
[6] Huang, J. et al. “Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.”American Journal of Psychiatry, vol. 167, no. 10, 2010, pp. 1253–62.
[7] Anttila, V. et al. “Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1.” Nature Genetics, vol. 42, no. 10, 2010, pp. 885–9.
[8] Jiang, Y. “Propensity score-based nonparametric test revealing genetic variants underlying bipolar disorder.” Genet Epidemiol, vol. 36, no. 2, 2012, pp. 106-112.
[9] Pilia, G., et al. “Heritability of cardiovascular and personality traits in 6,148 Sardinians.”PLoS Genetics, vol. 2, no. 8, 2006, p. e132.
[10] Levy, D., et al. “Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness.”BMC Medical Genetics, vol. 8, suppl. 1, 2007, p. S3.
[11] Yamada, Y., et al. “Genetic risk for myocardial infarction determined by polymorphisms of candidate genes in a Japanese population.” Journal of Medical Genetics, vol. 45, no. 4, 2008, pp. 216-221.
[12] Wang, Y., et al. “Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness.”Circulation, vol. 108, no. 15, 2003, pp. 1845-1851.